Your Account
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
Volume I: Neuropsychological Endophenotypes and Biomarkers
by None
(To see other currencies, click on price)
Paperback / softback
Add to basket  

(To see other currencies, click on price)
Add to basket  


Main description:

Neuropsychiatric disorders such as schizophrenia, mood disorders, Alzheimer’s disease, epilepsy, alcoholism, substance abuse and others are some of the most debilitating illnesses worldwide characterizing by the complexity of the causes, and lacking the laboratory tests that may promote diagnostic and prognostic procedures. Recent advances in neuroscience, genomic, genetic, proteomic and metabolomic knowledge and technologies have opened the way to searching biomarkers and endophenotypes, which may offer powerful and exciting opportunity to understand the etiology and the underlying pathophysiological mechanisms of neuropsychiatric disorders. The challenge now is to translate these advances into meaningful diagnostic and therapeutic advances.

This book offers a broad synthesis of the current knowledge about diverse topics of the biomarker and endophenotype strategies in neuropsychiatry. The book is organized into four interconnected volumes: “Neuropsychological Endophenotypes and Biomarkers” (with overview of methodological issues of the biomarker and endophenotype approaches in neuropsychiatry and some technological advances), “Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers”, “Metabolic and Peripheral Biomarkers” and “Molecular Genetic and Genomic Markers”. The contributors are internationally and nationally recognized researchers and experts from 16 countries.

This four-volume handbook is intended for a broad spectrum of readers including neuroscientists, psychiatrists, neurologists, endocrinologists, pharmacologists, clinical psychologists, general practitioners, geriatricians, health care providers in the field of neurology and mental health interested in trends that have crystallized in the last decade, and trends that can be expected to further evolve in the coming years. It is hoped that this book will also be a useful resource for the teaching of psychiatry, neurology, psychology and mental health.


New tools for biomarker-discovery

Endophenotype strategy

Peripheral biomarkers for neuropsychiatric disorders

Neuroimaging biomarkers and endophenotypes

Neurocognitive biomarkers and endophenotypes

Pharmacogenetics and pharmacogenomics


Contributors Part I. Methodological and Technological Advances
1. Where do we stand in the quest for neuropsychiatric biomarkers and endophenotypes and what next? Michael S. Ritsner and Irving I. Gottesman
2. Methodological and statistical issues in the use of biomarkers in clinical and research studies. Ryan Van Lieshout and Peter Szatmari
3. Challenging the genetic complexity of schizophrenia by use of endophenotypes. Assen Jablensky
4. Translational medicine: functional biomarkers for drug development of 'cognitive enhancers' in schizophrenia. Georg Winterer
5. Leveraging high-dimensional neuroimaging data in genetic studies of neuropsychiatric disease. Cinnamon S. Bloss, Trygve E. Bakken, Alexander H. Joyner, Nicholas J. Schork
6. Proteomics as a new tool for biomarker-discovery in neuropsychiatric disorders. Thomas J. Raedler, Harald Mischak, Holger Jahn, Klaus Wiedemann
7. Schizophrenia endophenotypes as treatment targets. Stephen I. Deutsch, Barbara L. Schwartz, Richard B. Rosse, John Mastropaolo, Ayman H. Fanous, Abraham Weizman, Jessica A. Burket, Brooke L. Gaskins Part II. Neuropsychological, Neurocognitive and Neurophysiological Domains
8. Neuropsychological endophenotypes in schizophrenia and bipolar I disorder: yields from the Finnish family and twin studies. Annamari Tuulio-Henriksson, Jonna Perälä, Irving I. Gottesman and Jaana Suvisaari
9. Is more cognitive experimental psychopathology of schizophrenia really necessary? Challenges and opportunities. Angus MacDonald, III
10. Intellectual functioning as an endophenotype for schizophrenia. Odette de Wilde
11. Emotion recognition deficits as a neurocognitive marker of schizophrenia liability. Renata Schoeman, Dana J. H. Niehaus, Liezl Koen, Jukka M. Leppänen
12. The use of neurocognitiveendophenotypes in large-scale family genetic studies of schizophrenia. William P. Horan, Tiffany A. Greenwood, David L. Braff, Raquel E. Gur and Michael F. Green
13. Neurocognitive endophenotypes for bipolar disorder: evidence from case-control, family and twin studies. Eugenia Kravariti, Fergus Kane, Robin Murray
14. Trait and state markers of schizophrenia in visual processing. Yue Chen, Daniel Norton and Ryan McBain
15. Visual scanning abnormalities as biomarker for schizophrenia and bipolar disorder. Patricia E. G. Bestelmeyer
16. Biomarkers and endophenotypes in eating disorders. Carolina Lopez, Marion Roberts and Janet Treasure
17. Movement abnormalities: a putative biomarker of risk for psychosis. Vijay Mittal and Elaine Walker Afterword by Robert H. Belmaker
Contents of Volumes 2, 3, and 4
Contributors of Volumes 2, 3, and 4


ISBN-13: 9789048181339
Publisher: Springer (Springer Netherlands)
Publication date: October, 2010
Pages: 288
Weight: 715g
Availability: POD
Subcategories: General Issues, Genetics, Neurology, Neuroscience, Psychiatry
Related books
Publisher recommends


Average Rating